Early research (Phase 1)Study completedNCT03293992
What this trial is testing
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Who this might be right for
Glaucoma, Open-angleOcular Hypertension
Hoffmann-La Roche 27